Cytokinetics CYTK Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's tax on share settlement?
- Cytokinetics (CYTK) reported tax on share settlement of $841K in Q1 2026.
- How has Cytokinetics's tax on share settlement changed year-over-year?
- Cytokinetics's tax on share settlement increased by 6369.2% year-over-year, from $13K to $841K.
- What does tax on share settlement mean?
- Cash paid to cover taxes for employees when their stock awards vest.
- How do you interpret tax on share settlement?
- Higher payments generally correlate with higher levels of stock-based compensation or increased share price performance at the time of vesting.
- How does tax on share settlement compare across companies?
- Common in companies with significant equity-based compensation structures; varies based on vesting schedules.